欧州の分子診断市場:産業分析、市場規模、市場シェア、成長、動向、予測

◆英語タイトル:Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Test Products (Polymerase chain reaction, Non-amplified tests, and Isothermal nucleic acid amplification technology; Hospitals, Public health laboratories, and Others) - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2015 - 2023
◆商品コード:TMR607135
◆発行会社(調査会社):Transparency Market Research
◆発行日:2016年4月22日
◆ページ数:64
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:欧州
◆産業分野:産業未分類
◆販売価格オプション(消費税別)
Single UserUSD3,795 ⇒換算¥432,630見積依頼/購入/質問フォーム
Multi UserUSD6,795 ⇒換算¥774,630見積依頼/購入/質問フォーム
Corporate LicenseUSD9,795 ⇒換算¥1,116,630見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTransparency Market Research社の日本における正規販売代理店です。Transparency Market Research社の概要及び新刊レポートはこちらでご確認いただけます。
【レポートの概要】

Nucleic acid tests are used for rapid and accurate identification of microbes. This report on molecular diagnostic market for group A streptococcus (GAS) nucleic acid (NA) test products in Europe analyses the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. This section also provides the overall information and data analysis of the nucleic acid test products market in Europe with respect to the leading market segments based on type of test techniques, end-user, and geography.The market overview section of the report includes qualitative analysis of the nucleic acid test product market in Europe including the factors determining the market dynamics such as drivers, restraints, and opportunities, along with Porter’s Five Forces Analysis. In addition, various analyses such as market attractiveness analysis by geography and competitive landscape by key players have been provided. The market attractiveness analysis explains the intensity of competition in the market in different geographies. The competitive scenario between market players is evaluated through market share analysis. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their shares in the European market.
The nucleic acid test product market in Europe has been segmented based on type of test technique, end-user, and geography. Based on type of test technique, the nucleic acid test market has been categorized into three major segments: polymerase chain reaction, non-amplified tests, and isothermal nucleic acid amplification technology. Based on end-user, the nucleic acid test product market in Europe has been segmented into five types: Hospitals, public health laboratories, and others. Market revenue in terms of US$ Mn for the period between 2013 and 2023 along with the compound annual growth rate (CAGR %) from 2015 to 2023 is provided for all the segments, considering 2014 as the base year.
Geographically, the nucleic acid test product market in Europe has been categorized into five regions: Western Europe, Northern Europe, Southern Europe, Eastern Europe, and Rest of Europe. Western Europe comprises France, Germany, Austria, and Rest of Western Europe. Northern Europe includes Ireland, Norway, Sweden, the U.K. and Northern Ireland, and Rest of Central Europe. Southern Europe comprises Italy, Spain, Portugal, and Rest of Southern Europe. Eastern Europe comprises Poland, the Czech Republic, Ukraine, Russian Federation, and Rest of Eastern Europe. The recommendations section included in the report would assist existing players to expand their market share and new companies to establish their presence in the market. The report also profiles major players in the nucleic acid test product market in Europe based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Alere, Inc., F. Hoffmann-La Roche Ltd., Hologic, Inc., Meridian Bioscience, Inc., Nanosphere, Inc., and Quidel Corporation.
The molecular diagnostic market for group A streptococcus (GAS) nucleic acid (NA) tests in Europe has been segmented as follows:
European Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Tests Products, by Type of Technique
o Isothermal nucleic acid amplification technology (iNAT)
o Polymerase chain reaction
o Non-amplified Tests
European Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Test Products, by End-user
o Hospitals
o Public Health Laboratories
o Others (referenced and clinical laboratories)
European Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Test Products, by Geography
o Northern Europe
o Ireland
o Norway
o Sweden
o United Kingdom of Great Britain and Northern Ireland
o Eastern Europe
o Eastern Europe
o Ukraine
o Poland
o Czech Republic
o Russian Federation
o Rest of Eastern Europe
o Western Europe
o France
o Germany
o Austria
o Rest of Western Europe
o Southern Europe
o Italy
o Spain
o Portugal
o Rest of Southern Europe
o Rest of Europe (including Scandinavia, Mediterranean Europe, and Azerbaijan)

【レポートの目次】

Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation

Chapter 2 Executive Summary

Chapter 3 Europe Molecular Diagnostic Market for Group A Streptococcus (GAS) NA Tests Market Overview
3.1 Introduction
3.2 Market Dynamics
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunities
3.3 Porter’s Five Forces Analysis
3.3.1 Bargaining Power of Suppliers
3.3.2 Bargaining Power of Buyers
3.3.3 Threat of New Entrants
3.3.4 Threat of Substitutes
3.3.5 Competitive Rivalry
3.4 Patient Pool Analysis
3.4.1 Mild illness (Acute pharyngitis)
3.4.2 Severe illness (e.g. Pneumonia, necrotizing fasciitis, etc.)
3.5 Market Attractiveness Analysis: Europe Molecular Diagnostic Market for Group A Streptococcus (GAS) NA Tests Market, by Top Countries
3.6 Competitive Landscape, by Key Players, 2014

Chapter 4 Europe Molecular Diagnostic Market for Group A Streptococcus (GAS) NA Tests Market Revenue (US$ Mn), by Type of Test Technique, 2013–2023
4.1 Overview
4.2 Isothermal nucleic acid amplification technology (iNAT)
4.3 Polymerase chain reaction
4.4 Non-Amplified Tests

Chapter 5 Europe Molecular Diagnostic Market for Group A Streptococcus (GAS) NA Tests Market Revenue (US$ Mn), by End-user, 2013–2023
5.1 Overview
5.2 Hospitals
5.3 Public Health Laboratories
5.4 Others (Referenced and Clinical Laboratories)

Chapter 6 Europe Molecular Diagnostic Market for Group A Streptococcus (GAS) NA Tests Market Revenue (US$ Mn), by Major Regions and Countries, 2013–2023
6.1 Overview
6.2 Northern Europe
6.2.1 Ireland
6.2.2 Norway
6.2.3 Sweden
6.2.4 United Kingdom of Great Britain and Northern Ireland
6.2.5 Rest of Central Europe
6.3 Eastern Europe
6.3.1 Ukraine
6.3.2 Poland
6.3.3 Czech Republic
6.3.4 Russian Federation
6.3.5 Rest of Eastern Europe
6.4 Western Europe
6.4.1 France
6.4.2 Germany
6.4.3 Austria
6.4.4 Rest of Western Europe
6.5 Southern Europe
6.5.1 Italy
6.5.2 Spain
6.5.3 Portugal
6.5.4 Rest of Southern Europe
6.6 Rest of Europe (including Scandinavia, Mediterranean Europe, Azerbaijan, etc.)

Chapter 7 Current Trends and Historical Snapshot

Chapter 8 Company Profiles
8.1 Alere Inc.
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 Focus Diagnostics, Inc.
8.3 F. Hoffmann-La Roche Ltd.
8.4 Hologic, Inc.
8.5 Meridian Bioscience, Inc.
8.6 Nanosphere
8.7 Quidel Corporation



【レポートのキーワード】

分子診断

★調査レポート[欧州の分子診断市場:産業分析、市場規模、市場シェア、成長、動向、予測]販売に関する免責事項
★調査レポート[欧州の分子診断市場:産業分析、市場規模、市場シェア、成長、動向、予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆